GENE ONLINE|News &
Opinion
Blog

Cas9
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
New Cas9 Alternatives Give Mammoth Biosciences an Edge Over Other CRISPR companies
2020-10-25
CRISPR Pioneers Bag 2020 Nobel Prize in Chemistry
2020-10-07
Scientists Further Powerful Gene Editing Tech’s Caliber with Rapid, Low Cost COVID-19 Diagnosis
2020-09-06
Spotlight: New Hypercompact Megaphage Cas Enzyme (CasΦ) Shows Efficient Gene Editing
2020-08-16
CRISPR C-to-G Base Editors: A Therapeutic Promise
2020-07-31
Verve Therapeutic’s One Time Base Editing Treatment Cuts Down Cholesterol Levels in Blood
2020-06-30
Evolved Cas9 Facilitates CRISPR Access to Previously Unexplored Genomic Sites
2020-03-31
Jennifer Doudna Cofounded Mammoth Biosciences Bags $45M for CRISPR Based Diagnostics
2020-02-01
Broad Institute and Cyrus Biotech Join Hands to Develop Safe CRISPR
2019-12-05
Ignavibacterium Cas9 Beats Thermostability Record, Functions at 100 Degree Celsius
2019-11-14
The CRISPR-Cas9 Report Card
2018-06-14
LATEST
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
EVENT
Scroll to Top